Daily Stock List
BFC Financial Corp. (BFCF)
Zacks, OTCPicks, SmallCap Fortunes, and Stock Traders Chat reported on BFC Financial Corp. (BFCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 1980, BFC Financial Corp. is a diversified holding company whose shares trade on the OTC Markets Group’s OTCQB. The Company’s goal is to create long-term value for its shareholders through profitable growth of its portfolio companies and appreciation in the value of its investments. BFC Financial has its headquarters in Fort Lauderdale, Florida.
BFC Financial’s main holdings include an ownership interest in BBX Capital and an indirect interest in Bluegreen Corp. BFC currently owns roughly 51 percent of the issued and outstanding shares of BBX Capital's Class A Common Stock and all of the issued and outstanding shares of BBX Capital's Class B Common Stock. Together, these shares represent an approximately 51 percent equity interest and 74 percent voting interest in BBX Capital.
BBX Capital is engaged in the acquisition, ownership, management of, joint ventures and investments in real estate and real estate development projects, and also acquisitions, investments and management of middle market operating businesses.
Regarding Bluegreen, BFC owns a 54 percent equity interest in Woodbridge, the parent company of Bluegreen. BBX Capital owns the remaining 46 percent equity interest in Woodbridge. Bluegreen manages, markets and sells the Bluegreen Vacation Club. This is a flexible, points-based, deeded vacation ownership plan with over 180,000 owners, more than 65 owned or managed resorts, and access to greater than 4,500 resorts around the world.
Today, BFC Financial announced that its intention is to begin a cash tender offer to the shareholders of BBX Capital to purchase up to 4,771,221 shares of BBX Capital's Class A Common Stock at a purchase price of $20.00 per share.
In addition, today, BBX Capital reported financial results for Q4 and year ending December 31, 2014. For Q4 2014, BBX reported a net loss of ($2.2) million, or ($0.13) per diluted share, for the quarter ended December 31, 2014, in comparison to net income of $49.3 million, or $2.97 per diluted share, for the quarter ended December 31, 2013.
For Full Year 2014, BBX reported net income of $4.3 million, or $0.28 per diluted share, for the year ended December 31, 2014, in comparison to net income of $47.7 million, or $2.94 per diluted share, for the year ended December 31, 2013. As of December 31, 2014, BBX Capital had consolidated total assets of $392.9 million, and shareholders' equity of $309.8 million.
BBX Sweet Holdings is a wholly-owned subsidiary of BBX Capital. This past October it acquired the stock of Anastasia Confections, Inc., based in Orlando, Florida. During Q4 2014, BBX Sweet Holdings also acquired The Toffee Box, based in Carlsbad, California.
BFC Financial Corp. (BFCF), closed Tuesday's trading session at $3.26, up 15.60%, on 726,635 volume with 304 trades. The average volume for the last 60 days is 74,235 and the stock's 52-week low/high is $2.56/$4.33.
North American Oil & Gas Corp. (NAMG)
PennyStocks24, Pumps and Dumps, Haywire Viral Marketing, and SUPERSTOCKPLAYS reported earlier on North American Oil & Gas Corp. (NAMG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
North American Oil & Gas Corp. (NAMG) is an oil and gas company based in Ventura, California. It provides oil and gas production services. The Company is focusing on the San Joaquin Basin, onshore California, with existing foundation assets targeting exploration and exploitation of high impact oil and gas projects located close to infrastructure and existing discoveries.
NAMG has a balanced portfolio of multiple projects targeting near term oil opportunities and moderate to high impact exploration located close to existing discoveries. The Company looks to partner with companies to develop extensions to existing producing fields and also to establish new development opportunities supported by high quality 3-D seismic analysis.
The Company’s projects are grouped in the southern part of the San Joaquin Basin providing a technical and operational focus to the Company’s activities. Its project portfolio consists of 14 low risk to high risk appraisal/exploration prospects targeting light oil with 6.1-48.3mmboe of gross resource potential and an acreage play. NAMG is targeting near term oil with a high chance of success for reserves and production.
NAMG has three major project areas, shallow and deep, The Tejon Main prospect, the Tejon Extension prospect, and the White Wolf prospect. On the Tejon Ranch Main lease it holds a gross acreage of 4,300 and a net acreage of 426. On the Tejon Ranch Extension lease it holds 546 gross acres and 346 net acres. On the White Wolf leases it is participating in over 4,600 gross acres. The targets are fractured shale and sandstone reservoirs on large footwall structures associated with the White Wolf fault.
The Company holds a 40 percent working interest (WI) in the Tejon Footwall Main project, and are the operators. It holds a 75 percent WI in the Tejon Extension project, and are the operators of this prospect. Additionally, NAMG, the operator, holds a 50 percent WI in the White Wolf project.
Recently, NAMG announced that it executed a non-binding Term Sheet to raise $2,000,000 with a California-based fund. NAMG is working with the fund to finalize the terms of the Rule 506 private placement (without registration rights) and will provide more updates in due time. The funding proceeds will be used to fund future acquisitions it has identified and for working capital purposes.
North American Oil & Gas Corp. (NAMG), closed Tuesday's trading session at $0.005, down 9.09%, on 500,259 volume with 18 trades. The average volume for the last 60 days is 336,300 and the stock's 52-week low/high is $0.0055/$0.17.
HyperSolar, Inc. (HYSR)
Top Stock Picks, SmallCapStockPlays, TopPennyStockMovers, and The MicrocapNews reported earlier on HyperSolar, Inc. (HYSR), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
HyperSolar, Inc. is developing an innovative, low cost technology to make renewable hydrogen using sunlight and any source of water. This includes seawater and wastewater. The Santa Barbara, California-based Company’s solution is the HyperSolar H2Generator™. Its solar hydrogen generator eliminates the need for conventional electrolyzers. Hydrogen fuel usage produces pure water as the only by-product.
Through optimizing the science of water electrolysis at the nano-level, HyperSolar’s low cost nanoparticles mimic photosynthesis to efficiently use sunlight to separate hydrogen from water, to produce environmentally friendly renewable hydrogen. The Company’s research focuses on developing a low-cost and submersible hydrogen production particle that can split water molecules under the sun, imitating the central functions of photosynthesis. Each particle is a complete hydrogen generator, which contains a novel high voltage solar cell bonded to chemical catalysts by a proprietary encapsulation coating.
HyperSolar H2Generator™ Panels can be connected together to scale to any size system to meet application specific hydrogen requirements. HyperSolar’s intention, using its low cost method to produce renewable hydrogen, is to enable a world of distributed hydrogen production for renewable electricity and hydrogen fuel cell vehicles.
HyperSolar has achieved a major technological milestone in its pursuit of clean hydrogen fuel production, through eliminating an expensive hydrogen-oxygen separation process. This will considerably reduce the overall system cost of hydrogen fuel production from sunlight.
HyperSolar has entered into a one year agreement with the University of Iowa. The agreement is to help expedite the Company’s R&D efforts to reach its objective of producing commercially viable renewable hydrogen. The University of Iowa has a reputation for innovative advancements in renewable energy technologies and sustainable practices in and around the campus.
Today, HyperSolar announced that it jointly filed a full utility patent application with the University of California, Santa Barbara (UCSB) for the "method of manufacture of multi-junction artificial photosynthetic cells."
Mr. Tim Young, Chief Executive Officer of HyperSolar, said, "As hydrogen fuel technology continues to garner attention from the mainstream consumer as well as industrial sectors, the industry is set to become as competitive as solar and wind energies. As we work with our partners, the University of Iowa and University of California, Santa Barbara, to scale our process for producing completely renewable, or 'green hydrogen' at or near the point of distribution, HyperSolar will only become more prominent.”
HyperSolar, Inc. (HYSR), closed Tuesday's trading session at $0.0245, up 16.11%, on 6,355,116 volume with 177 trades. The average volume for the last 60 days is 2,619,899 and the stock's 52-week low/high is $0.0111/$0.075.
DigiPath Corp. (DIGP)
Otcstockexchange, Whisper from Wall Street, SmallCapStockPlays, Wallstreetbuzz, SmallCapVoice, and DSR News reported earlier on DigiPath Corp. (DIGP), and today we report on the Company, here at the QualityStocks Daily Newsletter.
DigiPath Corp. is a digital pathology solution provider that is quickly expanding into cannabis testing and related services. The National Marijuana News (TNMNews) is DigiPath’s unbiased cannabis news site and talk radio show. It concentrates on the political, economic, medicinal, and cultural dimensions of the fast developing medicinal and recreational marijuana industry.
In November 2014, DigiPath announced that it received approval from the State of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas, Nevada. The expectation is that the lab will open its doors to customers in early 2015. DigiPath is headquartered in Las Vegas.
DigiPath develops and markets accurate and affordable human and animal digital pathology solutions. The Company is expanding into the botanical, nutraceutical, and cannabis industries with industry-leading testing, education, and training services. Its systems enable entities to create, store, manage, analyze, as well as correlate data collected via virtual microscopy.
The Company’s line of advanced digital pathology and advisory solutions include marketing, product development, sales, outreach, operations, customer service, regulatory, and financial management services for the healthcare industry. DigiPath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using Food and Drug Administration (FDA)-compliant laboratory equipment and processes to ensure product and patient safety and effectiveness.
DigiPath Education and Training is developing a two-day seminar and a modularized six-week, instructor-facilitated online course. This is for people who wish to learn more about cannabis or who are seeking employment in the industry.
DigiPath has a digital pathology portfolio. PathScope™ is its’ whole slide imaging system. PathScope™ delivers high-quality real-time images and integrates smoothly with third-party software. PathLive™ is the Company’s telepathology system. It delivers high-quality images in real time. PathReview™ is DigiPath’s proprietary web viewer and image server management system for whole digital slide images.
PathConsult™ is its’ end-to-end digital pathology solution. PathConsult™ enables remote consultation and second opinions, strong reporting and workflow management for histotechnicians, pathologists and administrators. Moreover, DigiPath’s digital pathology solutions include PathCloud™, PathTrade™, PathStore™, and PathGuarentee™.
The National Marijuana News (TNMNews.com) is DigiPath's news and radio program. It has built up an audience of over 150,000 listeners monthly since its soft launch in June 2014. The program airs on a number of terrestrial radio stations. These include WXXM 92.1 AM (The Mic) in Madison, Wisconsin, and two stations in Alaska—KBYR 700 AM in Anchorage and KFAR 660 AM in Fairbanks.
DigiPath Corp. (DIGP), closed Tuesday's trading session at $0.0181, up 12.42%, on 512,687 volume with 19 trades. The average volume for the last 60 days is 189,238 and the stock's 52-week low/high is $0.0143/$6.00.
Elite Pharmaceuticals, Inc. (ELTP)
Top Stock Picks, Stock Analyzer, and PennyStocks24 reported on Elite Pharmaceuticals, Inc. (ELTP), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
OTCQB-listed Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. The Company also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Moreover, it has partnered with Epic Pharma for the manufacturing and distribution of 11 approved products pending manufacturing site, with Hi-Tech Pharmacal to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the U.S. market and its territories.
Elite Pharmaceuticals operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, New Jersey, the Company’s headquarters. Elite has eight commercial products now selling, a number of approved products pending manufacturing site transfer, and an additional product under review pending approval by the Food and Drug Administration (FDA).
Its lead pipeline products include abuse resistant opioids using its patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain that address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse.
Elite announced in July 2014 the first dosing of a pivotal bioequivalence study in healthy volunteers for ELI-201. This is the Company’s twice daily abuse deterrent oxycodone/naltrexone product, using Elite's proprietary pharmacological abuse deterrent technology. The study is an open-label, single-dose, partially-randomized crossover study in healthy adult subjects.
The primary objective of this study is to compare the bioavailability and establish bioequivalence of ELI-201 controlled-release capsules, 40 mg to OxyContin® controlled-release tablet, 40 mg. The secondary objectives include ascertaining the bioavailability of oxycodone from ELI-201 under fasted and fed conditions and evaluating the safety and tolerability of ELI-201.
Elite Pharmaceuticals announced this past December successful results from the pivotal bioequivalence (BE) study for ELI-201. The study demonstrated the Company’s product is bioequivalent to the branded drug based on pharmacokinetic measures. The study was a single dose, open label, randomized, cross-over study in healthy volunteers with 34 subjects conducted under fasted conditions. Final findings of bioequivalence are dependent upon FDA review.
In February, Elite Pharmaceuticals announced guidance concerning its Phase III trial for ELI-200, which is an abuse deterrent opioid product. The Company has submitted a study protocol to the FDA. The expectation is that dosing for the study will commence shortly after the FDA comments on the protocol are received by Elite Pharmaceuticals.
The Phase III study will enroll approximately 150 patients. The study is a multi-center, randomized, multiple-dose, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of abuse deterrent ELI-200 for the treatment of adults with moderate to severe pain following surgery.
Elite Pharmaceuticals, Inc. (ELTP), closed Tuesday's trading session at $0.2544, up 3.37%, on 1,944,440 volume with 294 trades. The average volume for the last 60 days is 1,465,397 and the stock's 52-week low/high is $0.1745/$0.591.
Baristas Coffee Company, Inc. (BCCI)
PennyStockRumors.net, PricelessPennyStocks, SmallCapVoice, SuperNovaElite, and Top Stock Picks reported earlier on Baristas Coffee Company, Inc. (BCCI), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Baristas Coffee Company, Inc. established to create a national brand of drive-thru espresso stands. The Company is accomplishing this through acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas Coffee Company is the largest and fastest growing costume-themed drive through Espresso Company in the nation. Additionally, Baristas has now started opening locations in shopping malls. The Company has its headquarters in Kent, Washington.
Currently, Baristas can be found in seven greater Seattle area locations, and also in Florida, and Montana. Baristas Coffee Company has company owned locations and has started franchising. The Company has its theme of joining attractive female baristas in entertaining costumes preparing what the Company believes are the finest beverages available on the market.
Baristas offers its customers hot and cold beverages, specializing in specialty coffees, blended teas, and other custom drinks. In addition, it offers smoothies, fresh-baked pastries and other confections. In season, it adds beverages including hot apple cider, hot chocolate, frozen coffees, and more. Another revenue stream for the Company is in promoting and selling Baristas™ merchandise; alluring calendars, mugs, t-shirts, and hats.
Baristas Coffee Company has purchased its first mobile espresso trailer to be used as a semi-permanent and mobile drive through/walk up sales and promotions vending location. The 15 foot self-contained Health Department approved unit is complete. It has operated successfully for an extended period under another brand. The mobile has undergone a complete retrofit to ensure maximum Baristas branding and quality of products.
The new mobile concept will be positioned at different semi-permanent and transient locations near areas of construction, parking lots, fairs, sporting events, nightclubs, and concerts throughout the year. The unit may also be used as a temporary Baristas during construction of new locations.
Last month, Baristas Coffee Company announced that it is opening its second location with eight state master franchise partner BMOC Partners in Johnstown, Pennsylvania. BMOC is a regional hospitality and Franchise operations company. The location is along the mall's primary corridor. It will allow for cafe seating nearby. An opening date by May 1, 2015 is anticipated.
Today, Baristas Coffee Company announced that in support of the national retail grocery and online distribution plan developed for the new Baristas White Coffee and Espresso Roast K-cups, the Company has placed the first in a series of National magazine advertisements. The new line of Baristas K-Cups will be available to buy through on-line retailers, and in a growing number of retail locations nationwide. The Baristas K-Cups will be supported by a multi-tiered advertising program designed to create brand awareness and build sales to support the grocery outlets and retail locations, which will be distributing the Baristas K-Cup line.
Baristas Coffee Company, Inc. (BCCI), closed Tuesday's trading session at $0.0493, up 9.56%, on 1,262,330 volume with 83 trades. The average volume for the last 60 days is 1,525,066 and the stock's 52-week low/high is $0.025/$0.178.
Blue Line Protection Group, Inc. (BLPG)
Today we are reporting on Blue Line Protection Group, Inc. (BLPG), here at the QualityStocks Daily Newsletter.
Blue Line Protection Group, Inc. is at the vanguard in providing regulatory compliance, security consultation and protection services to high-value asset industries. It provides secured transportation, state and federal regulatory compliance, security consultation and training, and professional protection services to these industries. The Company is a highly trained asset protection business and the nation’s premier cash-based business security and Protection Company. Blue Line Protection Group is based in Colorado.
Blue Line’s security operators, investigations personnel, as well as consulting staff are highly trained professionals with major experience in law enforcement and the United States armed forces. The Company provides top-tier security services to clients who want the best in regulatory compliance, professional protection, and armed transportation services.
Blue Line Protection Group is now offering its Cannabis Industry Security and Protection Academy (CISPA). This is being offered to industry professionals nationwide. The Company formed its CISPA training program to develop and deliver consistent cannabis industry protection training to security and compliance professionals who desire to enter the expanding legal cannabis industry.
Furthermore, Blue Line Protection Group’s National Academy for Protection Professionals offers security and protections groups from across the nation the opportunity to grow their businesses in the expanding legalized cannabis industry.
Concerning Compliance, Blue Line provides on-site consultation and investigative services to ensure a business remains compliant with state and federal guidelines. Regarding Security for retail, the Company has professional security operators with law enforcement and military experience to provide first-rate protection services. Pertaining to Transportation, Blue Line has licensed, bonded, and insured protection and transportation professionals dedicated to the safe and timely delivery of valuable cargo.
Recently, Blue Line Protection Group announced the expansion of its security contract with LaConte's Clone Bar and Dispensary in Denver, Colorado. Blue Line Protection Group's former law enforcement and military professionals will provide customer validation and verification and security services for cannabis product and the dispensaries' cash tax payments to government revenue agencies. The expansion of Blue Line's services boosts its gross revenue from LaConte's Clone Bar and Dispensary from $102,000 to approximately $185,000 annually.
Blue Line Protection Group, Inc. (BLPG), closed Tuesday's trading session at $0.214, up 12.63%, on 438,995 volume with 84 trades. The average volume for the last 60 days is 22,342 and the stock's 52-week low/high is $0.06/$1.7857.
Cleartronic, Inc. (CLRI)
The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.105, up 16.67%, on 51,260 volume with 6 trades. The stock’s average daily volume over the past 60 days is 827, and its 52-week low/high is $0.04/$0.5499.
Cleartronic, Inc. announced today that it has entered into a new employment agreement with Larry Reid, the Company's Chief Executive Officer. The agreement calls for the cancellation of two billion common shares held by Mr. Reid. Cleartronic also announced American Media Group, Inc., a public relations and marketing firm will assist the Company in advertising, broadcasting, and developing its marketing strategies for its ReadyOp™ platform.
Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.
VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.
A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.
Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer
Cleartronic, Inc. Company Blog
Cleartronic, Inc. News:
Cleartronic, Inc. (CLRI) Adds Shareholder Value With Cancellation of Two Billion Shares of Common Stock Held by CEO
Cleartronic Announces Expanded License Agreement With Collabria LLC
Cleartronic Appoints Two New Members to Board of Directors
Inventergy Global, Inc. (INVT)
The QualityStocks Daily Newsletter would like to spotlight Inventergy Global, Inc. (INVT). Today, Inventergy Global, Inc. closed trading at $0.8244, up 16.94%, on 1,432,132 volume with 1,809 trades. The stock’s average daily volume over the past 60 days is 54,541, and its 52-week low/high is $0.3904/$12.92.
Inventergy Global, Inc. today announced operational restructuring and process improvements for the product-based businesses of its wholly-owned subsidiary, eOn Communications Systems, Inc. ("ECS"), to strategically position the company to increase earnings, reduce costs, improve cash flow and build shareholder value. ECS is managed by its President Stephen Swartz.
Inventergy Global, Inc. (INVT) is an intellectual property (IP) licensing partner specializing in IP value creation. Led by industry veteran Joe Beyers, former head of global licensing for Hewlett-Packard, Inventergy identifies, acquires and licenses patented technologies to help market-leading technology companies monetize and achieve more value from their innovations.
With more than 100 years of combined experience and track record of handling more than $15 billion in IP and technology transactions, Inventergy’s team of professionals handle every aspect of the IP business, from valuation and branding through legal analysis, decision making and patent sales.
Inventergy partners with world-class, market-significant companies who may lack internal manpower, budget or other resources necessary to realize appropriate return-on-investment. Through collaborative, business-centered, and forward-thinking strategies, Inventergy is able to create portfolios with significant market potential and optimize the innovator’s overall return-on-investment.
The company has established a network of key industry relationships to complement its solid licensing model and growing portfolio of assets, which currently stands at more than 760 global patent assets. Inventergy pursues maturing telecommunications technologies already adopted in the marketplace and earning accretive value. Disclaimer
Inventergy Global, Inc. Company Blog
Inventergy Global, Inc. News:
Inventergy Announces Operational Restructuring of Its Product Businesses Designed to Improve Margins, Cash Flow and Earnings Growth
Inventergy Launches Standardized Licensing Initiative for Mobile Device Manufacturers
Inventergy Invited to Present at the 27th Annual ROTH Conference
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.06025, up 3.88%, on 868,690 volume with 64 trades. The stock’s average daily volume over the past 60 days is 503,256, and its 52-week low/high is $0.0555/$0.241.
International Stem Cell Corp. announced today that the Japan Patent Office has granted ISCO's patent covering methods of making a bank of human stem cells from parthenogenetically activated eggs, significantly strengthening the company's intellectual property position and partnering ability in Japan. Along with ISCO's substantial collection of US patents, and the recently announced resolution by the European Union Court of Justice in favor of the company's EU patent applications, this new Japanese patent provides intellectual property protection and licensing opportunities for ISCO in the three largest healthcare markets.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Receives Key Stem Cell Patent in Japan
International Stem Cell Corporation Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial
International Stem Cell Corporation to Conduct Parkinson's Disease Clinical Study in Australia
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.016, up 45.45%, on 1,472,867 volume with 55 trades. The stock’s average daily volume over the past 60 days is 149,076, and its 52-week low/high is $0.011/$0.785.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program
Save The World Air, Inc. (ZERO)
The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.495, up 5.32%, on 236,484 volume with 60 trades. The stock’s average daily volume over the past 60 days is 127,044, and its 52-week low/high is $0.3401/$0.95.
Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.
In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.
The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.
STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.
Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer
Save The World Air, Inc. Company Blog
Save The World Air, Inc. News:
STWA Reports 2014 Year-End Financial Results and Provides Operational Update
STWA Sets Date for Its Year-End 2014 Earnings Results Release and Conference Call
STWA Deploys AOT(TM) Viscosity Reduction System on Condensate Pipeline in Eagle Ford
Zenosense, Inc. (ZENO)
The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.155, up 3.33%, on 21,937 volume with 9 trades. The stock’s average daily volume over the past 60 days is 31,743, and its 52-week low/high is $0.13/$1.00.
Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.
Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.
The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.
Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.
Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer
Zenosense, Inc. Company Blog
Zenosense, Inc. News:
Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial
Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible
Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device
Sibling Group Holdings, Inc. (SIBE)
The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.053, up 0.96%, on 166,301 volume with 21 trades. The stock’s average daily volume over the past 60 days is 100,142, and its 52-week low/high is $0.05/$0.24.
Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.
Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.
Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.
IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer
Sibling Group Holdings, Inc. Company Blog
Sibling Group Holdings, Inc. News:
Sibling Group Announces Strategic Partnership for Global Growth; $3.75 Million Investment to Grow Business in China and Other Markets
Sibling Group's Urban Planet Mobile Announces Partnership for Writing Planet in Hong Kong Secondary Schools
Sibling Group's Urban Planet Mobile(TM) Enters Indian Market, Announces New Mobile Distribution
Today's Top 3
Beacon Equity Research
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Adds Shareholder Value With Cancellation of Two Billion Shares of Common Stock Held by CEO
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- eCareer Holdings, Inc. (ECHI) Reports 1000% Increase in Openreq.com Site Traffic, Seeks to Expand Salesforce
- Falcon Crest Energy (FCEN) Acquires Remaining Working Interest in Rocky Ford Field
- IFAN Financial, Inc. (IFAN) Reaches Technology Development Milestones
- International Stem Cell Corp. (ISCO) Receives Key Stem Cell Patent in Japan
- Inventergy Global, Inc. (INVT) Announces Operational Restructuring of Its Product Businesses Designed to Improve Margins, Cash Flow and Earnings Growth
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Purchases Majority of North American Shopping Network From Domark International
- One World Holdings, Inc. (OWOO) The One World Doll Project CEO Announces 2015 Revenue Projections in Stockholder Letter
- Pure Hospitality Solutions, Inc. (PNOW) Photo Share To Boost Oveedia Valuations
- Resort Savers, Inc. (RSSV) Closes $2M Investment
- Save The World Air, Inc. (ZERO) Reports 2014 Year-End Financial Results and Provides Operational Update
- Sibling Group Holdings, Inc. (SIBE) Announces Strategic Partnership for Global Growth; $3.75 Million Investment to Grow Business in China and Other Markets
- Sparta Commercial Services, Inc. (SRCO) Reports Continued Sales Growth
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial